← Open Payments lookup

GENEVIEVE ALLOU: Open Payments

NPI 1942836960 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,981 in 90 payments from 16 companies in 2025. Trend: 2023 $2,819 · 2024 $3,271 · 2025 $1,981

Food & beverage: $1,981
CompanyPaymentsAmount
ABBVIE INC.26$442
Madrigal Pharmaceuticals11$312
Gilead Sciences, Inc.10$270
Ardelyx, Inc.7$238
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$214
Takeda Pharmaceuticals U.S.A., Inc.8$168
GENZYME CORPORATION4$115
Intercept Pharmaceuticals, Inc.3$52
Janssen Biotech, Inc.2$35
Boston Scientific Corporation1$24

Products named: REZDIFFRA, IBSRELA, XIFAXAN, LINZESS, RINVOQ, DUPIXENT, ENTYVIO, MAVYRET.

Industry payments across NE — which companies pay providers there.